JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 22, 2013 | $1,430,000 | Replaced |
| 1st Quarter - Amendment (this page) | Jul 22, 2013 | $2,070,000 | Yes |
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
- Issues related to current and future trade negotiations. - Issues related to TransPacific Partnership trade negotiations. - Issues related to TransAtlantic Trade and Investment Partnership negotiations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Health Issues HCR
- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Alzheimer's research. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - S 622, "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013", regarding all provisions. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - PL 11229, "Leahy-Smith America Invents Act" and issues related to patent trolls. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| GREGORY ARONIN | — |
| DON BOHN | — |
| BRIAN BURNS | — |
| JULIE D COHEN | — |
| KIMBERLY DAVIS | — |
| LAURYL DODSON JACKSON | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
| CHARLES NAU | — |
| MARK REESE | — |
Environment/Superfund ENV
- Issues related to chemicals in the environment. - PL 94-469, "Toxic Substances Control Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
Medicare/Medicaid MMM
- Issues related to Medicare reimbursement for Clinical Laboratory Services. - HR 8, "American Taxpayer Relief Act of 2012", regarding all provisions in Section 636. - HR 800, "To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare", regarding all provisions.- Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues related to implantable medical devices. - Issues related to diabetes testing supplies. - Issues related to competitive bidding of diabetes care products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
| JULIE D COHEN | — |
| KIMBERLY DAVIS | — |
| LAURYL DODSON JACKSON | — |
| MARK REESE | — |
Law Enforcement/Crime/Criminal Justice LAW
- Issues regarding the theft of medical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK REESE | — |
Consumer Issues/Safety/Products CSP
- Issues related to dextromethorphan. - Issues related to pseudoephedrine. - Issues related to the regulation of cosmetic products. - HR 1385, "Safe Cosmetics and Personal Care Products Act of 2013", regarding all provisions.- S 644, "Preventing Abuse of Cough Treatments Act of 2013", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DON BOHN | — |
| DARREL C JODREY | — |
Budget/Appropriations BUD
- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to deficit reductions/fiscal cliff.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
| BRIAN BURNS | — |
| JULIE D COHEN | — |
| DARREL C JODREY | — |
| CHARLES NAU | — |
| MARK REESE | — |
Financial Institutions/Investments/Securities FIN
- HR 1135, "Burdensome Data Collection Relief Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Taxation/Internal Revenue Code TAX
- Issues regarding tax reform. - HR 1248, "Family Health Care Flexibility Act", regarding all provisions. - Issues related to tax legislation. - Issues related to Ways and Means tax reform discussion draft.- HR 523, "Protect Medical Innovation Act of 2013", regarding all provisions. - HR 1295, "Medical Device Tax Elimination Act", regarding all provisions. - S 232, "Medical Device Access and Innovation Protection Act", regarding all provisions. - HR 1129, "Mobile Workforce State Income Tax Simplification Act of 2013", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| DON BOHN | — |
| BRIAN BURNS | — |
| JULIE D COHEN | — |
| KIMBERLY DAVIS | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.